ESPE Abstracts

^aDepartment of Pediatrics, Institute of Metabolic Science, University of Cambridge, Cambridge, UK; ^bDepartment of Growth and Reproduction, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; ^cMRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK; ^dDepartment of Endocrinology, Birmingham Children’s Hospital, Birmingham, UK; ^eDepartment of Endocrinology, Royal Hospital for Sick Children, Glasgow, UK; ^fDepartment of Clinical Sciences, Endocrine and Diabetes Unit, University of Lund, Lund, Sweden; ^gPediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institutet and University Hospital, Stockholm, Sweden; ^hDepartment of Pediatrics, The National Children’s Hospital, University of Dublin, Trinity College, Dublin, Ireland

Manchester Academic Health Sciences Centre, Royal Manchester Children’s Hospital, Manchester, UK

^aRoyal Manchester Children’s Hospital, Manchester, UK; ^bDépartement de Pédiatrie, Université Claude Bernard, Lyon, France

Department of Pediatrics, Göteborg Pediatric Growth Research Centre, The University of Gothenburg, Gothenburg, Sweden

^aDepartment of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; ^bFaculty of Medicine, University of Calgary, Calgary, Alberta, Canada; ^cDivision of Pediatric Endocrinology, Alberta Children’s Hospital, Calgary, Alberta, Canada

^aPrometheon Pharma, LLC, Alachua, Florida, USA; ^bSid Martin Biotechnology Institute (University of Florida), Alachua, Florida, USA